Tenuifolin in the prevention of Alzheimer's disease‐like phenotypes: Investigation of the mechanisms from the perspectives of calpain system, ferroptosis, and apoptosis
Authors:
- 26 June 2023
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 37 (10) , 4621-4638
Abstract
Polygala tenuifolia was documented to calm the mind and promote wisdom. However, its underlying mechanisms are still unclear. This study aimed to investigate the mechanisms underlying the effects of tenuifolin (Ten) on Alzheimer's disease (AD)‐like phenotypes. We first applied bioinformatics methods to screen the mechanisms of P. tenuifolia in the treatment of AD. Thereafter, the d‐galactose combined with Aβ1–42 (GCA) was applied to model AD‐like behaviors and investigate the action mechanisms of Ten, one active component of P. tenuifolia. The data showed that P. tenuifolia actioned through multi‐targets and multi‐pathways, including regulation of synaptic plasticity, apoptosis, and calcium signaling, and so forth. Furthermore, in vitro experiments demonstrated that Ten prevented intracellular calcium overload, abnormal calpain system, and down‐regulation of BDNF/TrkB signaling induced by GCA. Moreover, Ten suppressed oxidative stress and ferroptosis in HT‐22 cells induced by GCA. Calpeptin and ferroptosis inhibitor prevented the decrease of cell viability induced by GCA. Interestingly, calpeptin did not interrupt GCA‐induced ferroptosis in HT‐22 cells but blocked the apoptosis. Animal experiments further demonstrated that Ten prevented GCA‐induced memory impairment in mice and increased synaptic protein expression while reducing m‐calpain expression. Ten prevents AD‐like phenotypes through multiple signaling by inhibiting oxidative stress and ferroptosis, maintaining the stability of calpain system, and suppressing neuronal apoptosis.Keywords
This publication has 44 references indexed in Scilit:
- Calcium and ROS: A mutual interplayRedox Biology, 2015
- Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulationNeuroscience Letters, 2015
- Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic miceHuman Molecular Genetics, 2014
- Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?Oxidative Medicine and Cellular Longevity, 2014
- Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: A comprehensive analysis of the central and peripheral nervous systemsNeuroscience, 2012
- Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathologyThe FASEB Journal, 2011
- Modulatory profiling identifies mechanisms of small molecule-induced cell deathProceedings of the National Academy of Sciences, 2011
- Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating PropertyPLOS ONE, 2010
- Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptorsCell Calcium, 2010
- Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2008